- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.19 Å
- Oligo State
- homo-14-mer
- Ligands
- 14 x 01: (6~{S},9~{a}~{S})-6-(3-azidopropyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide
01.1: 15 residues within 4Å:- Chain A: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190, E.193
- Chain G: V.45, L.49, F.50, A.53, H.83
11 PLIP interactions:7 interactions with chain A, 4 interactions with chain G- Hydrophobic interactions: A:D.27, A:I.29, A:Y.61, A:Y.63, A:I.93, G:V.45, G:L.49, G:L.49, G:A.53
- Hydrogen bonds: A:D.27
- Halogen bonds: A:R.23
01.3: 14 residues within 4Å:- Chain A: V.45, L.49, F.50, A.53, H.83
- Chain B: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
10 PLIP interactions:3 interactions with chain A, 7 interactions with chain B- Hydrophobic interactions: A:V.45, A:L.49, A:A.53, B:D.27, B:I.29, B:Y.61, B:Y.63, B:I.93
- Hydrogen bonds: B:D.27
- Halogen bonds: B:R.23
01.5: 14 residues within 4Å:- Chain B: V.45, L.49, F.50, A.53, H.83
- Chain C: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
11 PLIP interactions:9 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:D.27, C:I.29, C:Y.61, C:Y.63, C:I.93, B:L.49, B:L.49
- Hydrogen bonds: C:D.27, C:D.27, C:Y.61
- Halogen bonds: C:R.23
01.6: 15 residues within 4Å:- Chain C: V.45, L.49, F.50, Q.52, A.53, H.83
- Chain D: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
14 PLIP interactions:8 interactions with chain D, 6 interactions with chain C- Hydrophobic interactions: D:D.27, D:I.29, D:Y.61, D:Y.63, D:I.93, C:V.45, C:L.49, C:L.49, C:A.53
- Hydrogen bonds: D:D.27, D:D.27, C:Q.52, C:Q.52
- Halogen bonds: D:R.23
01.7: 14 residues within 4Å:- Chain D: V.45, L.49, F.50, A.53, H.83
- Chain E: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
8 PLIP interactions:6 interactions with chain E, 2 interactions with chain D- Hydrophobic interactions: E:D.27, E:I.29, E:Y.61, E:Y.63, E:I.93, D:L.49, D:A.53
- Halogen bonds: E:R.23
01.8: 16 residues within 4Å:- Chain E: V.45, L.49, F.50, Q.52, A.53, T.80, H.83
- Chain F: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
12 PLIP interactions:5 interactions with chain E, 7 interactions with chain F- Hydrophobic interactions: E:V.45, E:L.49, E:A.53, E:T.80, F:D.27, F:I.29, F:Y.61, F:Y.63, F:I.93
- Hydrogen bonds: E:Q.52, F:D.27
- Halogen bonds: F:R.23
01.9: 14 residues within 4Å:- Chain F: V.45, L.49, F.50, A.53, H.83
- Chain G: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
12 PLIP interactions:8 interactions with chain G, 4 interactions with chain F- Hydrophobic interactions: G:D.27, G:I.29, G:Y.61, G:Y.63, G:I.93, F:V.45, F:L.49, F:L.49, F:A.53
- Water bridges: G:D.27, G:D.27
- Halogen bonds: G:R.23
01.11: 16 residues within 4Å:- Chain H: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
- Chain N: V.45, L.49, F.50, Q.52, A.53, H.83, K.85
10 PLIP interactions:4 interactions with chain N, 6 interactions with chain H- Hydrophobic interactions: N:V.45, N:L.49, N:A.53, H:D.27, H:I.29, H:Y.61, H:Y.63, H:I.93
- Hydrogen bonds: N:Q.52
- Halogen bonds: H:R.23
01.13: 15 residues within 4Å:- Chain I: V.45, L.49, F.50, Q.52, A.53, H.83
- Chain J: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
12 PLIP interactions:5 interactions with chain I, 7 interactions with chain J- Hydrophobic interactions: I:V.45, I:L.49, I:A.53, J:D.27, J:I.29, J:Y.61, J:Y.63, J:I.93
- Hydrogen bonds: I:Q.52, I:H.83, J:D.27
- Halogen bonds: J:R.23
01.14: 14 residues within 4Å:- Chain H: V.45, L.49, F.50, A.53, H.83
- Chain I: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
12 PLIP interactions:8 interactions with chain I, 4 interactions with chain H- Hydrophobic interactions: I:I.29, I:Y.61, I:Y.63, I:I.91, I:I.91, I:I.93, H:V.45, H:L.49, H:L.49, H:A.53
- Hydrogen bonds: I:D.27
- Halogen bonds: I:R.23
01.15: 16 residues within 4Å:- Chain J: V.45, L.49, F.50, Q.52, A.53, H.83
- Chain K: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190, E.193
11 PLIP interactions:5 interactions with chain J, 6 interactions with chain K- Hydrophobic interactions: J:V.45, J:L.49, J:L.49, J:A.53, K:I.29, K:Y.61, K:Y.63, K:I.93
- Water bridges: J:A.53
- Hydrogen bonds: K:D.27
- Halogen bonds: K:R.23
01.16: 16 residues within 4Å:- Chain K: V.45, L.49, F.50, A.53, H.83
- Chain L: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190, V.191, E.193
13 PLIP interactions:4 interactions with chain K, 9 interactions with chain L- Hydrophobic interactions: K:V.45, K:L.49, K:L.49, K:A.53, L:D.27, L:I.29, L:Y.61, L:Y.63, L:I.93
- Hydrogen bonds: L:D.27, L:D.27, L:E.193
- Halogen bonds: L:R.23
01.17: 14 residues within 4Å:- Chain L: V.45, L.49, F.50, A.53, H.83
- Chain M: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
12 PLIP interactions:9 interactions with chain M, 3 interactions with chain L- Hydrophobic interactions: M:D.27, M:I.29, M:Y.61, M:Y.63, M:Y.63, M:I.93, L:V.45, L:L.49, L:A.53
- Hydrogen bonds: M:D.27, M:D.27
- Halogen bonds: M:R.23
01.18: 15 residues within 4Å:- Chain M: V.45, L.49, F.50, Q.52, A.53, H.83
- Chain N: R.23, L.24, D.27, I.29, Y.61, Y.63, I.91, I.93, M.190
12 PLIP interactions:4 interactions with chain M, 8 interactions with chain N- Hydrophobic interactions: M:L.49, M:L.49, M:A.53, N:D.27, N:I.29, N:Y.61, N:Y.63, N:I.93
- Hydrogen bonds: M:Q.52, N:D.27, N:D.27
- Halogen bonds: N:R.23
- 3 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- 1 x TBU: TERTIARY-BUTYL ALCOHOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, T. et al., Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against Staphylococcus aureus Infection. J.Med.Chem. (2025)
- Release Date
- 2025-02-19
- Peptides
- ATP-dependent Clp protease proteolytic subunit: ABCDEFGHIJKLMN
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
N
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.19 Å
- Oligo State
- homo-14-mer
- Ligands
- 14 x 01: (6~{S},9~{a}~{S})-6-(3-azidopropyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide
- 3 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- 1 x TBU: TERTIARY-BUTYL ALCOHOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, T. et al., Structure-Guided Development of ClpP Agonists with Potent Therapeutic Activities against Staphylococcus aureus Infection. J.Med.Chem. (2025)
- Release Date
- 2025-02-19
- Peptides
- ATP-dependent Clp protease proteolytic subunit: ABCDEFGHIJKLMN
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
N